IN8bio, Inc.
INAB
$0.1449
$0.01219.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.21% | -3.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.06% | 3.03% | |||
| Operating Income | 9.06% | -3.03% | |||
| Income Before Tax | 9.90% | 13.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.90% | 13.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.90% | 13.07% | |||
| EBIT | 9.06% | -3.03% | |||
| EBITDA | 10.02% | -3.20% | |||
| EPS Basic | 16.77% | 46.63% | |||
| Normalized Basic EPS | 16.63% | 37.23% | |||
| EPS Diluted | 12.39% | 46.63% | |||
| Normalized Diluted EPS | 16.63% | 37.23% | |||
| Average Basic Shares Outstanding | 8.25% | 62.96% | |||
| Average Diluted Shares Outstanding | 8.25% | 62.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||